These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 39060163)

  • 1. Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder.
    Ewens AN; Pilski A; Hastings SD; Krook-Magnuson C; Graves SM; Krook-Magnuson E; Thayer SA
    J Pharmacol Exp Ther; 2024 Sep; 391(1):104-118. PubMed ID: 39060163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat.
    Raybuck JD; Hargus NJ; Thayer SA
    J Neurosci; 2017 Aug; 37(33):7837-7847. PubMed ID: 28716964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model.
    Sanchez PE; Zhu L; Verret L; Vossel KA; Orr AG; Cirrito JR; Devidze N; Ho K; Yu GQ; Palop JJ; Mucke L
    Proc Natl Acad Sci U S A; 2012 Oct; 109(42):E2895-903. PubMed ID: 22869752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Region-specific effects of HIV-1 Tat on intrinsic electrophysiological properties of pyramidal neurons in mouse prefrontal cortex and hippocampus.
    Cirino TJ; Harden SW; McLaughlin JP; Frazier CJ
    J Neurophysiol; 2020 Apr; 123(4):1332-1341. PubMed ID: 32101482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Strauss M; O'Donovan B; Ma Y; Xiao Z; Lin S; Bardo MT; Ortinski PI; McLaughlin JP; Zhu J
    J Pharmacol Exp Ther; 2020 Aug; 374(2):241-251. PubMed ID: 32461322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDARs Adapt to Neurotoxic HIV Protein Tat Downstream of a GluN2A-Ubiquitin Ligase Signaling Pathway.
    Green MV; Thayer SA
    J Neurosci; 2016 Dec; 36(50):12640-12649. PubMed ID: 27810933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega 3 polyunsaturated fatty acids enhance the protective effect of levetiracetam against seizures, cognitive impairment and hippocampal oxidative DNA damage in young kindled rats.
    Abdel-Wahab BA; Shaikh IA; Khateeb MM; Habeeb SM
    Pharmacol Biochem Behav; 2015 Aug; 135():105-13. PubMed ID: 26044965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Allosteric Modulator Southern Research Institute-32743 Reverses HIV-1 Transactivator of Transcription-Induced Increase in Dopamine Release in the Caudate Putamen of Inducible Transactivator of Transcription Transgenic Mice.
    Davis SE; Ferris MJ; Ananthan S; Augelli-Szafran CE; Zhu J
    J Pharmacol Exp Ther; 2023 Feb; 384(2):306-314. PubMed ID: 36456195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.
    Fitting S; Ignatowska-Jankowska BM; Bull C; Skoff RP; Lichtman AH; Wise LE; Fox MA; Su J; Medina AE; Krahe TE; Knapp PE; Guido W; Hauser KF
    Biol Psychiatry; 2013 Mar; 73(5):443-53. PubMed ID: 23218253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory Control Deficits Associated with Upregulation of CB
    Jacobs IR; Xu C; Hermes DJ; League AF; Xu C; Nath B; Jiang W; Niphakis MJ; Cravatt BF; Mackie K; Mukhopadhyay S; Lichtman AH; Ignatowska-Jankowska BM; Fitting S
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):661-678. PubMed ID: 31372820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.
    Talos DM; Chang M; Kosaras B; Fitzgerald E; Murphy A; Folkerth RD; Jensen FE
    Pediatr Res; 2013 Jan; 73(1):24-30. PubMed ID: 23138400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.
    Langford D; Oh Kim B; Zou W; Fan Y; Rahimain P; Liu Y; He JJ
    J Neurovirol; 2018 Apr; 24(2):168-179. PubMed ID: 29143286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.
    Boido D; Farisello P; Cesca F; Ferrea E; Valtorta F; Benfenati F; Baldelli P
    Neuroscience; 2010 Nov; 171(1):268-83. PubMed ID: 20804820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulations.
    Marks WD; Paris JJ; Schier CJ; Denton MD; Fitting S; McQuiston AR; Knapp PE; Hauser KF
    J Neurovirol; 2016 Dec; 22(6):747-762. PubMed ID: 27178324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of α7 nicotinic acetylcholine receptor ameliorates HIV-associated neurology and neuropathology.
    Zhao X; Wilson K; Uteshev V; He JJ
    Brain; 2021 Dec; 144(11):3355-3370. PubMed ID: 34196664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IL-1β Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt-Jakob Disease.
    Bertani I; Iori V; Trusel M; Maroso M; Foray C; Mantovani S; Tonini R; Vezzani A; Chiesa R
    J Neurosci; 2017 Oct; 37(43):10278-10289. PubMed ID: 28924012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam.
    Meehan AL; Yang X; McAdams BD; Yuan L; Rothman SM
    J Neurophysiol; 2011 Sep; 106(3):1227-39. PubMed ID: 21653714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice.
    Shi JQ; Wang BR; Tian YY; Xu J; Gao L; Zhao SL; Jiang T; Xie HG; Zhang YD
    CNS Neurosci Ther; 2013 Nov; 19(11):871-81. PubMed ID: 23889921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam has an activity-dependent effect on inhibitory transmission.
    Meehan AL; Yang X; Yuan LL; Rothman SM
    Epilepsia; 2012 Mar; 53(3):469-76. PubMed ID: 22292611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice.
    Zhu J; Quizon PM; Wang Y; Adeniran CA; Strauss MJ; Jiménez-Torres AC; Patel P; Cirino TJ; Eans SO; Hammond HR; Deliscar LS; O'Hara P; Saini SK; Ofori E; Vekariya RH; Zhang S; Moukha-Chafiq O; Nguyen TH; Ananthan S; Augelli-Szafran CE; Zhan CG; McLaughlin JP
    Neuropharmacology; 2022 Dec; 220():109239. PubMed ID: 36126727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.